ContraVir Pharmaceuticals Appoints Two New Hepatitis B Experts to Scientific Advisory Board

    NEXT STORY
    VBL Therapeutics Awarded $2.5 Million Non-Dilutive Grant by the Israel Innovation Authority
    PREV STORY
    Enzymatica AB: New ColdZyme study in elite athletes confirms preventive effect and reduced duration of illness
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Agios Announces FDA Orphan Drug Designation Granted to Mitapivat for Treatment of Sickle Cell Disease

    author_avatar
    NASDAQ Market News

    Zai Lab Announces Upcoming Presentation at 39th Annual J.P. Morgan Healthcare Conference

    author_avatar
    NASDAQ Market News

    Checkpoint Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights

    NEW YORK, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), ...

    author_avatar
    NASDAQ Market News